Insider trade

Palisade Bio (PALI): Director bought ~$50K

Robert Jr. Baltera, Director at Palisade Bio, bought ~$50K of Palisade Bio shares.

~$50K
Approx. value · 50K sh @ $1.01
512K
Holds after · shares reported
Traded
Nov 17, 2026
Filed
Nov 19, 2026

What stands out in this filing

  • The purchase added 10.8% to the shares this insider held before it; the filing reports 511,904 shares afterwards.
  • 50,000 shares at an average of $1.01 each, as reported on the form.
  • The first open-market purchase by this insider in 4 months.
  • PALI closed at $1.01 on Nov 17, 2026, at its 52-week low, after a 32% drop over the previous 30 trading days.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 1, 2026Insider · Their largest buy since 2023Director purchased ~$14K of PALI shares in the open market
  2. Oct 2, 2026InsiderDirector purchased ~$15K of PALI shares in the open market
  3. Oct 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 5.2%
  4. Nov 9, 20265% stakeSoleus Capital Master Fund, L.P. reported a passive stake (13G) of 8.6%
  5. Nov 10, 2026Company filing · Form 8-K · ResultsReported its results
  6. Nov 16, 20265% stakeAmeriprise Financial, Inc. reported a passive stake (13G) of 8.4%
  7. Nov 16, 20265% stakeRA Capital Management, L.P. reported a passive stake (13G) of 9.9%
  8. Nov 17, 2026 · this disclosureInsiderDirector purchased ~$50K of PALI shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Palisade Bio

For Palisade Bio, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PALI page.

Other recent filings by Robert Jr. Baltera, Director

The full history of Robert Jr. Baltera, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Palisade Bio (PALI) insider traded, and how much?

Robert Jr. Baltera, Director at Palisade Bio, bought ~$50K of Palisade Bio shares. 50K shares at $1.01, open market.

When did it happen, and when was it made public?

Traded: Nov 17, 2026. Filed: Nov 19, 2026. That is 2 days between the two dates.

What stands out in this filing?

The purchase added 10.8% to the shares this insider held before it; the filing reports 511,904 shares afterwards. 50,000 shares at an average of $1.01 each, as reported on the form. The first open-market purchase by this insider in 4 months.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Palisade Bio recently?

For Palisade Bio, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the PALI page.

Does this mean PALI stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Palisade Bio

Everything OQRO holds on this company is on its PALI page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data